Psychiatry

 
US Adolescent Substance Use Holding Steady or Declining: Highlights from the 2024 Monitoring the Future Survey
January 02, 2025

Substances of choice used in the previous 12 months were alcohol, nicotine vaping, and cannabis but the trends among the 8th, 10th, and 12th graders are very encouraging.

Women are at Higher Genetic Risk for PTSD than Men, According to Large Twin-Sibling Study
December 19, 2024

In the largest twin-sibling study to date of the inherited biological risk of PTSD, researchers found additive genetic and unique environmental effects contributed to the disorder.

Brexpiprazole and Sertraline Combination Therapy Shows Efficacy in Treating PTSD
December 18, 2024

New findings highlight the potential of this combination therapy as a new option for people with PTSD who have not responded to standard treatments.

Delix Therapeutics Announces Results from Phase 1 Trial of DLX-001 for Major Depressive Disorder
December 13, 2024

A phase 1b and Phase 2 study are up next for the novel potential MDD treatment.

FDA Review Sought for Lumateperone as Adjunctive Therapy for Major Depressive Disorder
December 13, 2024

Intra-Cellular Therapies submitted an sNDA to the FDA for lumateperone for the treatment of MDD in adults as as adjunctive therapy to antidepressants.

Most US Adults Want Primary Care Physicians to Address Mental Health: Daily Dose
December 11, 2024

Your daily dose of the clinical news you may have missed.

Three-Quarters of US Adults Want to Be Asked About Mental Health in Primary Care Visits: New Survey
November 22, 2024

Approximately 70% of US adults surveyed hope their primary care clinician will ask about their mental health during an appointment, regardless of the presenting issue.

Depression, Anxiety in Youth with Chronic Pain: Daily Dose
October 15, 2024

Your daily dose of the clinical news you may have missed.

Effectiveness of Suicide Care Implementation in Primary Care: Daily Dose
October 14, 2024

Your daily dose of the clinical news you may have missed.

FDA Black-Box Warnings on Antidepressants Linked to Reduced Treatment, Increased Risk of Suicide Among Youth
October 08, 2024

The FDA warnings were intended to increase physician monitoring for suicidal thoughts and behaviors but have had dramatic unintended consequences.